De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Shenzhen Glory MedicalLtd Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Guiqiu Liang

Algemeen directeur

CN¥570.0k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	29.6%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	geen gegevens

Recente managementupdates

Recent updates

CEO

Guiqiu Liang (61 yo)

no data

Tenure

CN¥570,000

Compensatie

Mr. Guiqiu Liang serves as Chairman and General Manager of Shenzhen Glory Medical Co.,Ltd. Mr. Liang served as President of Shenzhen Glory Medical Co., Ltd.

Shenzhen Glory MedicalLtd Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Shenzhen Glory Medical Co.,Ltd., Annual General Meeting, May 14, 2024

Shenzhen Glory Medical Co.,Ltd., Annual General Meeting, May 22, 2023

Insufficient new directors

Shenzhen Glory Medical Co.,Ltd., Annual General Meeting, May 23, 2022

Recent updates

Shenzhen Glory Medical Co.,Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Second quarter 2024 earnings released: EPS: CN¥0 (vs CN¥0.006 in 2Q 2023)

Shenzhen Glory Medical Co.,Ltd. to Report First Half, 2024 Results on Aug 27, 2024

Full year 2023 earnings released: CN¥0.18 loss per share (vs CN¥0.36 loss in FY 2022)

Shenzhen Glory Medical Co.,Ltd., Annual General Meeting, May 14, 2024

Shenzhen Glory Medical Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Shenzhen Glory Medical Co.,Ltd. (SZSE:002551) announces an Equity Buyback for 2,000,000 shares, for CNY 8.58 million.

Shenzhen Glory Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.006 (vs CN¥0.001 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.006 (vs CN¥0.076 loss in 2Q 2022)

Shenzhen Glory Medical Co.,Ltd., Annual General Meeting, May 22, 2023

Full year 2022 earnings released: CN¥0.36 loss per share (vs CN¥0.071 profit in FY 2021)

Insufficient new directors

Third quarter 2022 earnings released: CN¥0.001 loss per share (vs CN¥0.001 profit in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.076 loss per share (vs CN¥0.029 profit in 2Q 2021)

Shenzhen Glory Medical Co.,Ltd., Annual General Meeting, May 23, 2022

First quarter 2022 earnings released: EPS: CN¥0.01 (vs CN¥0.06 in 1Q 2021)

Third quarter 2021 earnings released: EPS CN¥0.001 (vs CN¥0.04 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.061 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.20 (vs CN¥0.085 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.21 (vs CN¥0.085 in FY 2019)

New 90-day low: CN¥5.71

New 90-day low: CN¥6.07

New 90-day low: CN¥6.46

New 90-day low: CN¥6.88

New 90-day low: CN¥6.90

Third quarter earnings released

New 90-day low - CN¥7.03

Earnings released

Shenzhen Glory Medical Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

CEO

Tenure

Compensatie